Germany´s biggest Biotech event
This years "Deutschen Biotechnologietage" have been taken place for the eighth time. More than 900 participants from start-ups, universities, companies, funding bodies and public institutions met on the 18th and 19th of April in Berlin to discuss newest trends in the field. Highlight of this year’s event have been an address of the new German Mister of Economics, Peter Altmaier. In his 20 minutes speech he pointed out that biotechnology is an important future technology and he promised special efforts of the German government to further companies in the field. He announced a round table after the summer break as a kick off for a biotechnology agenda which is determinated in the coalition agreement. Altmaier himself initiated a discussion about an interdisciplinary agenda for the biotechnology early in 2017. The actions should correspond to the digital agenda and should guide Germany into a leading position in the world in the biotechnology sector.
SSS International Research took part in this years main event of the German biotech industry. As one of the most experienced companies in clinical research in Germany SSS can provide its clients with solutions tailored to their requirements. This is especially of value for young biopharma companies which have limited resources for clinical study planning and design.